4.0 Article

Official Positions for FRAX® Clinical Regarding Falls and Frailty: Can Falls and Frailty be Used in FRAX®?

期刊

JOURNAL OF CLINICAL DENSITOMETRY
卷 14, 期 3, 页码 194-204

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jocd.2011.05.010

关键词

Falls; fracture; FRAX; sarcopenia; frailty

资金

  1. Medical Research Council [MC_UP_A620_1014] Funding Source: Medline
  2. Medical Research Council [U1475000001, MC_UP_A620_1014] Funding Source: researchfish
  3. National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish

向作者/读者索取更多资源

Risk factors for fracture can be purely skeletal, e.g., bone mass, microarchitecture or geometry, or a combination of bone and falls risk related factors such as age and functional status. The remit of this Task Force was to review the evidence and consider if falls should be incorporated into the FRAX (R) model or, alternatively, to provide guidance to assist clinicians in clinical decision-making for patients with a falls history. It is clear that falls are a risk factor for fracture. Fracture probability may be underestimated by FRAX (R) in individuals with a history of frequent falls. The substantial evidence that various interventions are effective in reducing falls risk was reviewed. Targeting falls risk reduction strategies towards frail older people at high risk for indoor falls is appropriate. This Task Force believes that further fracture reduction requires measures to reduce falls risk in addition to bone directed therapy. Clinicians should recognize that patients with frequent falls are at higher fracture risk than currently estimated by FRAX (R) and include this in decision-making. However, quantitative adjustment of the FRAX (R) estimated risk based on falls history is not currently possible. In the long term, incorporation of falls as a risk factor in the FRAX (R) model would be ideal.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据